Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
Fondazione del Piemonte per l'Oncologia
Dana-Farber Cancer Institute
Mayo Clinic
Hoffmann-La Roche
STORM Therapeutics LTD
Psyence Australia Pty Ltd
Eastern Cooperative Oncology Group
Neonc Technologies, Inc.
ViroMissile, Inc.
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
AstraZeneca
Pfizer
Radiopharm Theranostics, Ltd
Arvinas Inc.
Immatics US, Inc.
Tizona Therapeutics, Inc
BioInvent International AB
Essen Biotech
Essen Biotech
Genentech, Inc.
St. Jude Children's Research Hospital
DualityBio Inc.
MacroGenics
xCures
Daiichi Sankyo
Beijing Tide Pharmaceutical Co., Ltd
University of Nebraska
National Institutes of Health Clinical Center (CC)
Second Life Therapeutics
ImmunityBio, Inc.
Elephas
Innate Pharma
Novartis
Elephas
OncoNano Medicine, Inc.
City of Hope Medical Center
Mayo Clinic
University of Pittsburgh
University Health Network, Toronto
GV20 Therapeutics
NeoTX Therapeutics Ltd.
Cancer Research UK